Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

Ruth Pettengell, FRACP, PhD, Pier Luigi Zinzani, MD, PhD, Geetha Narayanan, MD, Fernando Hurtado de Mendoza, MD, Raghunadharao Digumarti, MD, Henry Gomez, MD, Bertrand Coiffier, MD, PhD, Gary Schiller, MD, David A. Rizzieri, MD, Paul Cernohous, MS, Lixia Wang, PhD, Jack Singer, MD

Blood (2010) 116 (21): 2833.

https://doi.org/10.1182/blood.V116.21.2833.2833

Published: 2010

Journal Articles

Phase III Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma (EXTEND): Results From the Treatment and Follow-up Periods.

Ruth Pettengell, MD, Bertrand Coiffier, MD, Geetha Narayanan, MD, Fernando Hurtado de Mendoza, MD, Raghunadharao Digumarti, MD, Henry Gomez, MD, Pier Luigi Zinzani, MD, Gary J Schiller, MD, David A Rizzieri, MD, Paul Cernohous, Lixia Wang, Jack W. Singer, MD

Blood (2009) 114 (22): 1677.

https://doi.org/10.1182/blood.V114.22.1677.1677

Published: 2009

Journal Articles

Osteonecrosis of the Jaw Related to Bisphosphonates Therapy in Multiple Myeloma and Metastatic Prostate Cancer Patients. A Latin American Report: An Adverse Event To Look For!!.

Brady Beltran, MD, Luis Riva, MD, Daniel del Carpio, MD, Ivan Fernandez, MD, Luis Vera, MD, Rocio Reategui, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo, MD, Antonio A. Carrasco-Yalan, MD

Blood (2007) 110 (11): 5162.

https://doi.org/10.1182/blood.V110.11.5162.5162

Published: 2007

Journal Articles

Epstein-Barr Virus Status Correlates with Poor Outcome and Is an Independent Prognostic Variable in De Novo Nodal Diffuse Large B Cell Lymphoma in Peru.

Brady Beltran, MD, Domingo Morales, MD, Luis Riva, MD, Fernando Hurtado de Mendoza, MD, Pilar Quinones, MD, Alejandro Yabar, MD, Antonio A. Carrasco-Yalan, MD

Blood (2007) 110 (11): 4391.

https://doi.org/10.1182/blood.V110.11.4391.4391

Published: 2007

Journal Articles

Alemtuzumab in Patients with Advanced Mycosis Fungoids: First Interim Report.

Brady E. Beltrán-Gárate, MD, Julia Huamani-Zavala, MD, Alfredo Aronés-Valdivia, MD, Antonio A. Carrasco-Yalan, MD, Fernando Hurtado de Mendoza, Henry L. Gómez-Moreno, MD

Blood (2006) 108 (11): 4728.

https://doi.org/10.1182/blood.V108.11.4728.4728

Published: 2006

Journal Articles

Cutaneous Lymphomas: Single Institution Experience in Lima-Peru.

Brady E. Beltrán-Gárate, MD, José Malaga, MD, Karen Portugal, MD, Domingo Morales, MD, Luis Riva, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo-Aguirre, MD, Pilar Quiñones, MD, Antonio A. Carrasco-Yalan, MD

Blood (2006) 108 (11): 4619.

https://doi.org/10.1182/blood.V108.11.4619.4619

Published: 2006

Journal Articles

FOXP3 Expression in Diverse T-Cell Lymphomas.

Brady E. Beltrán-Gárate, MD, Pilar Quiñones, MD, Domingo Morales, MD, Julia Huamani-Zavala, PharmD, Osbert Mejía, MD, Miriam Vidurrizaga, MD, Jose Malaga, MD, Jorge Castillo-Aguirre, MD, Luis Riva, MD, Fernando Hurtado de Mendoza, MD, Antonio A. Carrasco-Yalan, MD

Blood (2006) 108 (11): 4760.

https://doi.org/10.1182/blood.V108.11.4760.4760

Published: 2006

Journal Articles

Clinical Outcomes in Adult T Leukemia/Lymphoma: Report of 55 Cases from Peru.

Brady E. Beltrán-Gárate, MD, Antonio A. Carrasco-Yalan, MD, Olga M. Lopéz-Odría, MD, Luis Riva-Gonzales, MD, Hugo Ríos, MD, Gloria Chumpitáz-Anchiraico, MD, Silvia Falcón-Lisarazo, MD, Juan Navarro-M, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo-Aguirre, MD

Blood (2005) 106 (11): 4797.

https://doi.org/10.1182/blood.V106.11.4797.4797

Published: 2005

NARROW

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

Phase III Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma (EXTEND): Results From the Treatment and Follow-up Periods.

Osteonecrosis of the Jaw Related to Bisphosphonates Therapy in Multiple Myeloma and Metastatic Prostate Cancer Patients. A Latin American Report: An Adverse Event To Look For!!.

Epstein-Barr Virus Status Correlates with Poor Outcome and Is an Independent Prognostic Variable in De Novo Nodal Diffuse Large B Cell Lymphoma in Peru.

Alemtuzumab in Patients with Advanced Mycosis Fungoids: First Interim Report.

Cutaneous Lymphomas: Single Institution Experience in Lima-Peru.

FOXP3 Expression in Diverse T-Cell Lymphomas.

Clinical Outcomes in Adult T Leukemia/Lymphoma: Report of 55 Cases from Peru.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only